Retreatment in leprosy: a case-control study

• Autor(a) principal: Ximenes, Ricardo Arraes Alencar
• Data de Publicação: 2007
• Outros Autores: Gallo, Maria Eugênia Novinsk, Brito, Maria de Fátima de Medeiros
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Revista de Saúde Pública
• Texto Completo: https://www.revistas.usp.br/rsp/article/view/32276
• topic: Hanseníase^i2^sepidemiolo; Hanseníase^i2^stera; Hansenostáticos^i2^sadministração e dosa; Resultado de tratamento; Recidiva^i2^sprevenção e contr; Estudos de casos e controles; Leprosy^i1^sepidemiol; Leprosy^i1^sther; Leprostatic agents^i1^sadministration & dos; Treatment outcome; Recurrence^i1^sprevention & cont; Case-control studies

OBJECTIVE: To assess risk factors for retreatment of leprosy patients. METHODS: A case-control study with patients from two reference care units in Recife, northeastern Brazil, in 2003. The case group included retreated patients (N=155) and the control group comprised those patients who were not retreated (N=155) matched by year of diagnosis and health care unit. Univariate and multivariate analyses were conducted to test the associations and odds ratios and related 95% confidence intervals were estimated. RESULTS: The following factors were found to be significantly associated (p; 1 (OR=6.43; 95% CI=1.67;24.74), therapeutic regimen consisting of sulfone monotherapy (OR=10; 95% CI=0.01;0.78) and reports of household contacts (OR=2.2; 95% CI=0.24;0.85). CONCLUSIONS: The study findings reinforce that the use of dapsone monotherapy should be discontinued, and highlight the need for epidemiological monitoring of specific groups of leprosy patients after treatment completion through periodical clinical and laboratory evaluation. Further studies to explore the association between final bacterial index and retreatment are strongly recommended.